CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 39.411
EU - Europa 12.358
AS - Asia 8.500
SA - Sud America 509
AF - Africa 97
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 17
Totale 60.922
Nazione #
US - Stati Uniti d'America 38.844
SG - Singapore 3.189
RU - Federazione Russa 2.887
HK - Hong Kong 2.311
CN - Cina 2.139
IE - Irlanda 1.976
IT - Italia 1.694
UA - Ucraina 1.560
SE - Svezia 1.513
DE - Germania 982
GB - Regno Unito 694
CA - Canada 517
BR - Brasile 448
FI - Finlandia 380
VN - Vietnam 274
FR - Francia 224
TR - Turchia 152
ID - Indonesia 149
NL - Olanda 93
AT - Austria 85
IN - India 82
DK - Danimarca 75
JP - Giappone 42
BE - Belgio 39
MX - Messico 39
ZA - Sudafrica 34
CZ - Repubblica Ceca 25
AR - Argentina 21
AU - Australia 20
KR - Corea 18
IR - Iran 17
PL - Polonia 15
ES - Italia 13
MY - Malesia 13
RO - Romania 13
UZ - Uzbekistan 12
BG - Bulgaria 11
EU - Europa 11
GR - Grecia 11
BD - Bangladesh 10
EC - Ecuador 10
EG - Egitto 10
IQ - Iraq 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
MA - Marocco 9
NG - Nigeria 9
CL - Cile 8
HU - Ungheria 8
KE - Kenya 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
TH - Thailandia 8
LK - Sri Lanka 7
NO - Norvegia 7
TW - Taiwan 7
CO - Colombia 6
LT - Lituania 6
PT - Portogallo 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 5
AM - Armenia 5
BO - Bolivia 5
DZ - Algeria 5
IL - Israele 5
PH - Filippine 5
PK - Pakistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
CH - Svizzera 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MD - Moldavia 4
MU - Mauritius 4
SA - Arabia Saudita 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
JO - Giordania 3
PE - Perù 3
TT - Trinidad e Tobago 3
AL - Albania 2
CM - Camerun 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
UY - Uruguay 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
GT - Guatemala 1
IS - Islanda 1
LI - Liechtenstein 1
Totale 60.908
Città #
Ann Arbor 7.832
Woodbridge 4.349
Fairfield 4.239
Houston 3.080
Hong Kong 2.294
Singapore 2.105
Ashburn 1.962
Dublin 1.862
Jacksonville 1.804
Wilmington 1.791
Seattle 1.622
Cambridge 1.397
Dearborn 1.360
Chandler 1.355
Princeton 999
New York 811
Milan 659
Frankfurt am Main 565
Santa Clara 520
Lawrence 478
Altamura 453
Nanjing 414
Beijing 319
Lachine 309
San Diego 302
Dong Ket 171
Nanchang 143
Moscow 142
Shenyang 141
Andover 139
Jakarta 127
Hebei 120
Shanghai 120
Guangzhou 119
Falls Church 93
Ottawa 90
Los Angeles 89
Norwalk 87
Council Bluffs 85
Toronto 81
London 79
Jiaxing 78
Tianjin 74
Boardman 70
Changsha 66
Jinan 60
Vienna 54
Helsinki 51
Detroit 48
Nuremberg 48
Kunming 42
Washington 37
Ningbo 36
San Mateo 36
São Paulo 35
Zhengzhou 35
Brussels 34
Lissone 33
Hangzhou 31
Huizen 31
Mountain View 31
Fremont 30
Redmond 27
Rome 26
Hefei 25
Dallas 22
Philadelphia 21
Esslingen am Neckar 20
Hounslow 20
Taizhou 19
Groningen 18
Chicago 17
Düsseldorf 15
Edmonton 15
Fuzhou 15
Kilburn 14
Lappeenranta 14
Loreto 14
Rio de Janeiro 14
Chengdu 13
Phoenix 13
Pune 13
Tokyo 13
Brno 12
Istanbul 12
Munich 12
Busto Arsizio 11
Frontone 11
Taiyuan 11
The Dalles 11
University Park 11
Belo Horizonte 10
Bologna 10
Edinburgh 10
Hanoi 10
New Bedfont 10
San Francisco 10
Tappahannock 10
Buenos Aires 9
Carate Brianza 9
Totale 46.214
Nome #
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 306
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 299
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 278
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 274
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 266
Cardiopulmonary receptor regulation of renin release 265
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 261
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 260
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 260
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 246
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 243
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 235
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 234
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 234
Renal and antihypertensive effects of felodipine in hypertensive patients 224
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 218
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 215
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 212
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 210
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 208
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 205
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 205
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 203
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 201
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 200
Clinical evaluation of a new antihypertensive drug (Indapamide) 200
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 200
Treatment of hypertension: The ESH/ESC guidelines recommendations 199
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 197
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 195
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 195
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 193
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 191
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 186
Blood pressure control in hypertension. Pros and cons of available treatment strategies 186
The association between 24-h blood pressure patterns and left ventricular mechanics 185
Neurogenic abnormalities in masked hypertension 184
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 182
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 181
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 180
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 179
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 179
Left ventricular geometry and diastolic function in the hypertensive heart: impact of age. 178
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 177
Incident Left Ventricular Hypertrophy in Masked Hypertension 177
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 176
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 174
Masked hypertension: an independent predictor of organ damage 174
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 173
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 173
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 172
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 172
Metabolic syndrome and multiple organ damage in essential hypertension 171
Subclinical hyperthyroidism and biatrial function and mechanics: a two- and three-dimensional echocardiographic study 168
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 167
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 166
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 166
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 166
Right ventricular mechanics in patients with aortic stenosis and preserved ejection fraction: Is arterial hypertension a new player in the game? 166
Extreme dipping: Always means nocturnal hypotension? 166
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 165
Metabolic syndrome and target organ damage: Role of blood pressure 165
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 164
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 163
How does subclinical hyperthyroidism affect right heart function and mechanics? 162
Is the blunted fall in nighttime heart rate a marker of subclinical cardiac damage? 162
Prevalence and correlates of multiple organ damage in referred treated hypertensives: Data from the ETODH study 160
Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. 160
New-onset left atrial enlargement in a general population 159
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 158
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 158
Masked Hypertension and Left Atrial Dysfunction: A Hidden Association 158
Indexation of left ventricular mass to body surface area and height to allometric power of 2,7: is the difference limited to obese hypertensives? 157
Heart rate as a predictor of cardiovascular risk 157
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 156
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 156
Effects of the metabolic syndrome on right heart mechanics and function. 156
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 155
Management of hypertension in patients with left ventricular hypertrophy 155
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 155
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients 155
Radiotherapy-induced right ventricular remodelling: The missing piece of the puzzle 155
The Impact of White-Coat Hypertension on Cardiac Mechanics 155
Cardiac and carotid structure in patients with established hypertension and white-coat hypertension 154
The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients 154
Intriguing relationship between antihypertensive therapy and cancer 154
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 153
Is fetuin-A a biomarker of preclinical atherosclerosis in essential hypertension? 153
Heart and Prehypertension 153
Nocturnal hypertension and organ damage in dippers and nondippers 152
Home and ambulatory blood pressure in resistant hypertension 152
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 152
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 151
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 151
Metabolic syndrome and biventricular hypertrophy in essential hypertension 151
The Hyper-Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice 150
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 150
Nocturnal blood pressure in untreated essential hypertensives 150
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 149
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 149
Totale 18.480
Categoria #
all - tutte 237.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020914 0 0 0 0 0 0 0 0 0 0 646 268
2020/20219.462 546 504 811 1.000 621 919 1.068 1.097 773 949 401 773
2021/20226.263 472 536 887 442 392 367 359 406 415 380 515 1.092
2022/20236.265 1.083 1.784 392 399 364 1.078 83 304 400 69 211 98
2023/20245.314 142 111 112 187 915 1.377 963 84 741 105 57 520
2024/202510.762 921 1.945 411 669 1.380 386 519 484 2.087 1.927 33 0
Totale 62.990